STOCK TITAN

FACT II Acquisition signs non-redemption agreements

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

FACT II Acquisition Corp. entered into and intends to enter into additional non-redemption agreements with unaffiliated investors and/or shareholders ahead of its November 20, 2026 meeting. Participants would agree not to redeem, or to rescind redemption requests for, their Class A ordinary shares. The proposed extension would move the business-combination deadline from November 27, 2026 to November 25, 2027, subject to shareholder approval. The deadline to submit shares for redemption was November 18, 2026, at 5:00 p.m. Eastern Time.

If participants do not redeem their covered shares, the extension proposal is approved and effected, and the other agreement conditions are met—including completion of an initial business combination—FACT II has agreed to issue them Class A ordinary shares promptly after the business combination closes, no later than two business days afterward. Certain agreement parties intend to buy Public Shares on the open market at or below the approximately $10.82 redemption price per share as of November 16, 2026, and say they will not vote those purchased shares for the extension. The trust account held approximately $189,375,121.18 as of that date. FACT II says there is no assurance an incentive will be offered and actual terms may differ materially.

Filing Explained

If issued after the agreement conditions are met, the promised shares increase the share count and reduce existing holders’ percentage ownership; the filing says they are unregistered and rely on a Securities Act exemption.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Redemption price Approximately $10.82 per share As of November 16, 2026
Trust account balance Approximately $189,375,121.18 As of November 16, 2026
Current business-combination deadline November 27, 2026 Deadline before the proposed extension
Proposed business-combination deadline November 25, 2027 Subject to shareholder approval
Meeting November 20, 2026 at 10:00 a.m. Eastern Time Extraordinary general meeting currently scheduled to consider the extension proposal
Redemption submission deadline November 18, 2026 at 5:00 p.m. Eastern Time For Public Shares in connection with the meeting
Share issuance timing No later than two business days after closing Applies after the initial business combination, subject to agreement conditions
Non-Redemption Agreements regulatory
"form of Non-Redemption Agreement"
A non-redemption agreement is a contract in which a security holder agrees not to demand repayment, cashing out, or forced buyback of their shares or debt for a set period. Think of it like agreeing to leave money in a shared pot rather than asking for your portion back immediately; it preserves company cash flow and reduces near-term liabilities. Investors care because it affects a company’s short-term liquidity, the timing of potential payouts, and the predictability of future ownership or debt levels.
redemption rights financial
"do not exercise their redemption rights"
Redemption rights are contractual provisions that allow a holder of a security—such as preferred shares, bonds, or certain fund units—to require the issuer to buy back the security under specified conditions, often at a set price or by a defined formula. For investors they act like a return policy that offers a forced exit or downside protection, affecting a security’s value, liquidity and the issuer’s cash planning.
initial business combination financial
"consummation of the Company’s initial business combination"
An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.
Section 4(a)(2) regulatory
"exemption provided by Section 4(a)(2) of the Securities Act"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.
Regulation D regulatory
"Regulation D promulgated thereunder"
Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What would FACT II give investors who do not redeem their shares?

FACT II has agreed to issue qualifying participants Class A ordinary shares after the initial business combination closes, no later than two business days afterward, if they do not redeem their covered shares, the extension proposal is approved and effected, and the agreement conditions are satisfied.

What was FACT II’s redemption price per share?

The redemption price was approximately $10.82 per share as of November 16, 2026, based on approximately $189,375,121.18 in the trust account divided by the outstanding Public Shares.

What deadline extension is FACT II asking shareholders to approve?

The proposal would extend the business-combination deadline from November 27, 2026 to November 25, 2027. The extraordinary general meeting to consider the proposal is scheduled for November 20, 2026, at 10:00 a.m. Eastern Time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0002028935 00-0000000 0002028935 2026-11-18 2026-11-18 0002028935 FACT:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareAndOnehalfOfOneRedeemableWarrantMember 2026-11-18 2026-11-18 0002028935 FACT:ClassOrdinarySharesParValue0.0001PerShareIncludedAsPartOfUnitsMember 2026-11-18 2026-11-18 0002028935 FACT:WarrantsIncludedAsPartOfUnitsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member 2026-11-18 2026-11-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 18, 2026

 

FACT II ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

  001-42421   N/A

(State or other jurisdiction of

incorporation or organization)

  (Commission File Number)  

(IRS Employer

Identification Number)

 

14 Wall Street, 20th Floor

New York, New York

United States of America

  10005
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (212) 618-1798

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant   FACTU   Nasdaq Global Market
Class A ordinary shares, par value $0.0001 per share, included as part of the units   FACT   Nasdaq Global Market
Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   FACTW   Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On October 14, 2026, the FACT II Acquisition Corp., a Cayman Islands exempted company (the “Company”) filed a definitive proxy statement (as may be supplemented from time to time, the “Extension Proxy Statement”) for an extraordinary general meeting of its shareholders (the “Meeting”), currently scheduled to be held on November 20, 2026, at 10:00 a.m., Eastern Time, to approve, among other things, an amendment to the Company’s amended and restated memorandum and articles of association to extend the date by which the Company must consummate an initial business combination from November 27, 2026 to November 25, 2027 (the “Extension Amendment Proposal”). Defined terms used but not defined herein have the meanings set forth in the Extension Proxy Statement.

 

In connection with the Meeting, the deadline for holders of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class A ordinary shares”), issued in the Company’s initial public offering (the “Public Shares”) to submit their shares for redemption is 5:00 p.m. Eastern Time on November 18, 2026. On November 16, 2026, the most recent practicable date prior to the date of this Current Report on Form 8-K (this “Current Report”), the redemption price per share was approximately $10.82, based on the aggregate amount on deposit in the Company’s trust account of approximately $189,375,121.18 as of November 16, 2026 divided by the total number of then outstanding Public Shares.

 

On November 18, 2026, in connection with the Meeting, the Company entered into and intends to enter into one or more additional non-redemption agreements substantially in the form filed herewith as Exhibit 10.1 (collectively, the “Non-Redemption Agreements”) with one or more unaffiliated investors and/or shareholders of the Company, pursuant to which such investors and/or shareholders would agree not to redeem (or to validly rescind any redemption requests on) their Class A ordinary shares (the “Non-Redeemed Shares”) in connection with the Meeting. Subject to the satisfaction of the conditions set forth in the Non-Redemption Agreements, including, without limitation, the consummation of the Company’s initial business combination, in consideration for the foregoing commitment not to redeem the Non-Redeemed Shares, the Company has agreed to issue or cause to be issued to such investors and/or shareholders Class A ordinary shares, at the ratio set forth in the applicable Non-Redemption Agreement, promptly following the closing of the Company’s initial business combination (but no later than two (2) business days thereafter) if such investors and/or shareholders do not exercise their redemption rights with respect to their Non-Redeemed Shares in connection with the Meeting, and the Extension Amendment Proposal is approved and effected.

 

Certain parties to the Non-Redemption Agreements intend to purchase additional shares of Public Shares on the open market and that such purchases will be made at or below the redemption price and that such parties shall not vote such purchased shares in favor of the Extension Amendment Proposal.

 

The Non-Redemption Agreements are expected to increase the amount of funds that remain in the Company’s trust account following the Meeting, relative to the amount remaining in the trust account in the absence of the Non-Redemption Agreements.

 

NO ASSURANCES ARE MADE THAT A NON-REDEMPTION INCENTIVE OF ANY KIND WILL BE OFFERED AND THE ACTUAL TERMS OF ANY NON-REDEMPTION INCENTIVE MAY DIFFER MATERIALLY FROM THE TERMS DESCRIBED HEREIN.

 

The foregoing description of the form of Non-Redemption Agreement does not purport to be complete and is qualified in its entirety by reference to the form of Non-Redemption Agreement filed hereto as Exhibit 10.1, which is incorporated herein by reference.

 

Item 3.02. Unregistered Sales of Equity Securities.

 

Pursuant to the Non-Redemption Agreements as described above, the Company has agreed to issue, or cause to be issued, to the investors and/or shareholders party thereto Class A ordinary shares, subject to the satisfaction of the conditions set forth in the Non-Redemption Agreements, including, without limitation, the consummation of the Company’s initial business combination. The Class A ordinary shares to be issued pursuant to the Non-Redemption Agreements will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), and will be issued in reliance on an exemption from the registration requirements thereof provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.

 

The disclosure set forth under Item 1.01 of this Current Report with respect to the Non-Redemption Agreements is incorporated by reference into this Item 3.02.

 

1

 

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the Meeting, the Extension Amendment Proposal, the Non-Redemption Agreements, any issuance of Class A ordinary shares under the Non-Redemption Agreements and any purchases of Public Shares by the investors, the Company’s financial position, business strategy and the plans and objectives of management for future operations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. They involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by these statements. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this Current Report, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company’s control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. When the Company discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, the Company’s management. Actual results and shareholders’ value will be affected by a variety of risks and factors, including, without limitation, international, national and local economic conditions, merger, acquisition and business combination risks, financing risks, geo-political risks, acts of terror or war, and those risk factors described under the “Risk Factors” section of the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 13, 2026, the Company’s Quarterly Reports on Form 10-Q filed with the SEC on May 11, 2026, August 12, 2026 and November 12, 2026, in the Extension Proxy Statement and in other reports the Company files with the SEC. Many of the risks and factors that will determine these results and shareholders’ value are beyond the Company’s ability to control or predict.

 

All such forward-looking statements speak only as of the date of this Current Report. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on the Company’s behalf are qualified in their entirety by this “Cautionary Note Regarding Forward-Looking Statements” section.

 

Participants in the Solicitation

 

The Company and its directors and executive officers may be deemed participants under SEC rules in the solicitation of proxies from the Company’s shareholders in connection with the Extension Amendment Proposal and related matters. Information regarding the Company’s directors and executive officers is contained in the Extension Proxy Statement and the Company’s filings with the SEC.

 

Additional Information and Where to Find It

 

The Company urges investors, shareholders and other interested persons to read the Extension Proxy Statement as well as other documents filed by the Company with the SEC, because these documents will contain important information about the Company and the Extension Amendment Proposal. Shareholders may obtain copies of the Extension Proxy Statement, without charge, at the SEC’s website at www.sec.gov or by directing a request to the Company’s proxy solicitor, Sodali & Co., by calling (800) 662-5200 (toll-free), or banks and brokers can call (203) 658-9400, or by emailing fact.info@investor.sodali.com.

 

No Offer or Solicitation

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Form of Non-Redemption Agreement
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 18, 2026 FACT II ACQUISITION CORP.
   
  By: /s/ Adam Gishen
  Name: Adam Gishen
  Title: Chief Executive Officer

 

3

 

Filing Exhibits & Attachments

5 documents

Keep reading